Kangji Medical Holdings Limited Share Price

Equities

9997

KYG5215A1004

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 01:38:20 26/04/2024 pm IST 5-day change 1st Jan Change
7.27 HKD +0.28% Intraday chart for Kangji Medical Holdings Limited +10.99% +4.01%

Financials

Sales 2023 926M 128M 1B 10.66B Sales 2024 * 1.13B 156M 1.23B 13.05B Capitalization 8.18B 1.13B 8.83B 94.07B
Net income 2023 504M 69.56M 545M 5.8B Net income 2024 * 569M 78.53M 615M 6.55B EV / Sales 2023 5.45 x
Net cash position 2023 2.68B 369M 2.89B 30.8B Net cash position 2024 * 1.48B 204M 1.6B 17.01B EV / Sales 2024 * 5.91 x
P/E ratio 2023
14.8 x
P/E ratio 2024 *
14.1 x
Employees 1,003
Yield 2023
6.45%
Yield 2024 *
3.55%
Free-Float 29.52%
More Fundamentals * Assessed data
Dynamic Chart
Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023 CI
Kangji Medical Holdings' Profit Rises 5% in 2023 MT
Kangji Medical Holdings Limited Proposes Special Dividend for the year ended December 31, 2023, Payable on 18 July 2024 CI
Kangji Medical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Kangji Medical Holdings Limited Proposes Final Dividend for the Year Ended December 31, 2023, Payable on 18 July 2024 CI
Kangji Medical Holdings Unit Offloads Stake in Medical Instrument Company MT
Kangji Medical Holdings Limited commences an Equity Buyback Plan for 121,679,200 shares, representing 10% of its issued share capital, under the authorization approved on May 25, 2023. CI
Kangji Medical Holdings Limited initiates a Market Repurchase. CI
Kangji Medical Holdings Limited Announces CFO Changes CI
Kangji Medical Holdings Limited Announces the Resignation of Frances Fang Chovanec as Executive Director, Member of Environmental, Social and Governance Committee with Effective from September 15, 2023 CI
Kangji Medical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Wuhan Keqian Biology Elects Chairman, Vice Chairman MT
Kangji Medical Holdings Limited Approves Payment of Final Dividend for the Year Ended December 31, 2022, Payment Date Is 10 July 2023 CI
Kangji Medical Holdings Limited's Equity Buyback announced on October 11, 2022, has expired. CI
Yanlord Land Group Names Executive Deputy Chairman MT
More news
1 day+0.28%
1 week+10.99%
Current month+7.54%
1 month+6.60%
3 months+22.60%
6 months+11.85%
Current year+4.01%
More quotes
1 week
6.55
Extreme 6.55
7.37
1 month
6.51
Extreme 6.51
7.37
Current year
5.71
Extreme 5.71
7.97
1 year
5.71
Extreme 5.71
10.36
3 years
5.28
Extreme 5.28
14.42
5 years
5.28
Extreme 5.28
35.65
10 years
5.28
Extreme 5.28
35.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 01/04/01
Director of Finance/CFO 47 15/23/15
Chief Tech/Sci/R&D Officer 44 16/09/16
Members of the board TitleAgeSince
Director/Board Member 61 07/20/07
Director/Board Member 67 07/20/07
Director/Board Member 40 13/20/13
More insiders
Date Price Change Volume
26/24/26 7.27 +0.28% 1,468,000
25/24/25 7.25 -0.68% 500,500
24/24/24 7.3 +0.55% 1,390,000
23/24/23 7.26 +5.99% 1,981,000
22/24/22 6.85 +4.58% 761,000

Delayed Quote Hong Kong S.E., April 26, 2024 at 01:38 pm IST

More quotes
Kangji Medical Holdings Ltd is a China-based investment holding company mainly engaged in the design, development, manufacture and sale of minimally invasive surgical instruments and accessories. The Company's main products include disposable trocars, polymer ligation clips, disposable electrocoagulation forceps and other disposable products, which are used in gynecology and obstetrics, urology, general surgery and thoracic surgery. The Company distributes its products within the domestic market and to overseas markets.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.73 CNY
Average target price
9.25 CNY
Spread / Average Target
+37.45%
Consensus